This review summarizes the multiple mechanisms of TAM-mediated EGFR-TKIs resistance in NSCLC, including activation of bypass pathways, inhibition of T cell activity, M2-like polarization, and regulation of tumor cell phenotypes. This evidence concerns the gene EGFR and neoplasm.